Unicancer
Veronique Robert serves as the Chief Data Officer at Unicancer since January 2022, where leadership focuses on strategic initiatives in real-world health data and managing data warehouses while directing teams in Data Management, Data Engineering, and Business Intelligence. With prior experience as a Data Project Manager for the Onco Data Hub, Veronique has contributed significantly to oncology research. Additionally, Veronique worked at Aix-Marseille Université as an ESG Analytics professor, and has extensive freelance experience as a CSR & ESG analytics consultant supporting sustainable business transformation. Previous roles include Social Business Project Manager at Emmaüs Défi, Director of Sales Division at RWD, Global Account Manager at SAP, and various managerial positions in customer service and consulting from 1993 to 2009. Veronique holds a Master 2 in Data Analysis from Conservatoire National des Arts et Métiers and a Master 1 in Logistics from UVSQ.
This person is not in any teams
Unicancer
UNICANCER groups together the 20 French Comprehensive Cancer Centres (FCCCs) which are private, not-for-profit hospitals located across the French territory. FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education. They contribute to the public hospital service in accordance with statutory fees, with no additional charge. UNICANCER is one of the largest cancer care and research organisations in Europe. Via its R&D department, it sponsors clinical trials to improve cancer patients’ care and access to innovation, particularly in areas neglected by the pharmaceutical industry. UNICANCER is accredited by the French Ministry of Health and is eligible for public grants. The French Comprehensive Cancer Centres in numbers: • 20 sites located throughout the French territory • 19,000 employees • >135,000 patients hospitalised each year • Approximately 500 active clinical trials • 17% of the patients treated are included in a clinical trial (vs an average of 8.5% of cancer patients in France) • 19 molecular biology platforms certified by the French National Cancer Institute • 7 integrated cancerology research sites (SIRIC) certified by the French NCI (out of 8) • 12 early-phase clinical trial Centres (CLIP²) certified by the French NCI (out of 16) • 5th for global publications in oncology • 32% of French publications in oncology (articles in which FCCCs have participated) UNICANCER sponsors • 76 ongoing clinical trials (2016) • Including 5400 patients (2016) • From 270 investigator sites (2015), • With 20% located in other European countries